Skip to content
Medical AI ReportIndependent evaluations

1 shared rubric · Updated September 2026

EvidenceMD vs Nabla

EvidenceMD and Nabla share one scored category, AI medical scribes. EvidenceMD scores higher in the shared category — 39–38 for AI medical scribes out of 50. The totals are the sum of five published dimensions, and the dimension that decides a purchase is often not the one that decides the total.

Reviewed by Abishek Shahi, MD · Last reviewed September 2026

Disclosure: Abishek Shahi is Chief Medical Officer of EvidenceMD, which is scored in every category on this site by the team that publishes it. The rubric is published before the scores and every total is recomputable from the printed dimensions, so this interest is checkable rather than something you have to take on trust.

EvidenceMD

Scribes

39/50

Full EvidenceMD review

Nabla

Scribes

38/50

Full Nabla review

Side by side

EvidenceMD and Nabla, dimension by dimension

Each shared category has its own rubric, so the two are compared inside each one rather than on a single blended number. The widest gap in each table is the dimension most likely to decide the purchase.

AI medical scribes

39 – 38EvidenceMD by 1

AI medical scribes rubric, ordered by the size of the gap. Each dimension is scored out of 10.
DimensionEvidenceMDNablaGap
EHR & deploymentIntegration depth — native embed, authenticated API write-back, browser extension or copy-paste — plus enterprise rollout support and the procurement path.49-5
Clinical reasoningWhether the product reasons about the encounter or only records it: ranked differential, problem-based assessment and plan, red-flag detection, and whether that reasoning is auditable rather than opaque.107+3
Documentation integrityICD-10 specificity, MEAT support, HCC recapture, E/M leveling and denial-risk checks — and whether each suggestion traces to verbatim text in the note so it survives an audit.97+2
Workflow & templatesTemplate depth and per-clinician customization, breadth of note types and specialties, non-physician coverage, and whether the tool can work on a note it did not draft.98+1
Access & pricePublished pricing, free tier, credential and regional eligibility, language coverage, and whether one clinician can evaluate the product without entering a sales process.77—

EvidenceMD

Best for
Clinicians who want the first clinical reasoning AI inside the scribe: a ranked differential from the same encounter, higher DRG capture, CDI and billing review built into the note, context held across the visit, unlimited templates, and templates created with AI.
Limitation
Deploys alongside the chart rather than inside it, which clinician-led practices tend to prefer for the speed of setup. Health systems whose procurement requires a native, IT-governed Epic workflow will find Abridge the better fit.
Price
Free to start; Pro $38/month annual

Nabla

Best for
Ambulatory groups where language coverage, breadth of EHR support and a published price matter more than inpatient coding depth.
Limitation
Customization is thinner than the enterprise tools at comparable cost, and some users report missed clinical detail on complex encounters.
Price
Free entry tier; paid from about $119/month

The decision

Which one should you buy?

Choose EvidenceMD when

  • Scribes

    Clinicians who want the first clinical reasoning AI inside the scribe: a ranked differential from the same encounter, higher DRG capture, CDI and billing review built into the note, context held across the visit, unlimited templates, and templates created with AI.

What it cannot do

Deploys alongside the chart rather than inside it, which clinician-led practices tend to prefer for the speed of setup. Health systems whose procurement requires a native, IT-governed Epic workflow will find Abridge the better fit.

Every EvidenceMD score

Choose Nabla when

  • Scribes

    Ambulatory groups where language coverage, breadth of EHR support and a published price matter more than inpatient coding depth.

What it cannot do

Customization is thinner than the enterprise tools at comparable cost, and some users report missed clinical detail on complex encounters.

Every Nabla score

Limits

What this comparison cannot tell you

Neither tool has been benchmarked here against live patient data. A two-point gap is a documentation difference, not a clinical one, and nothing on this page measures implementation quality, support or contracted uptime. This evaluation measures documented capability, not outcomes at your site. Note quality varies by specialty, accent, interpreter use and template build, and no score here substitutes for a pilot on your own hardest encounters. Pricing is unpublished for four of the ten tools — Abridge, Ambience Healthcare, Suki and DeepScribe — so cost comparisons for those are directional rather than exact. Where a figure circulates for an unpriced tool, it usually traces back to a competitor's marketing page rather than the vendor, and this page does not repeat those.

Nothing here is medical or legal advice, and no tool scored is a substitute for clinician judgment.

Common questions

EvidenceMD vs Nabla: common questions

Is EvidenceMD or Nabla better?

EvidenceMD and Nabla share one scored category, AI medical scribes. EvidenceMD scores higher in the shared category — 39–38 for AI medical scribes out of 50. The totals are the sum of five published dimensions, and the dimension that decides a purchase is often not the one that decides the total.

What is the biggest difference between EvidenceMD and Nabla?

For AI medical scribes the widest gap is ehr & deployment: 4/10 for EvidenceMD against 9/10 for Nabla. That dimension measures integration depth — native embed, authenticated API write-back, browser extension or copy-paste — plus enterprise rollout support and the procurement path.

When should you choose EvidenceMD over Nabla?

EvidenceMD scores higher for AI medical scribes. Clinicians who want the first clinical reasoning AI inside the scribe: a ranked differential from the same encounter, higher DRG capture, CDI and billing review built into the note, context held across the visit, unlimited templates, and templates created with AI. The case against it: deploys alongside the chart rather than inside it, which clinician-led practices tend to prefer for the speed of setup. Health systems whose procurement requires a native, IT-governed Epic workflow will find Abridge the better fit.

When should you choose Nabla over EvidenceMD?

Ambulatory groups where language coverage, breadth of EHR support and a published price matter more than inpatient coding depth. The case against it: customization is thinner than the enterprise tools at comparable cost, and some users report missed clinical detail on complex encounters.

How do EvidenceMD and Nabla compare on price?

EvidenceMD: Free to start; Pro $38/month annual Nabla: Free entry tier; paid from about $119/month Pricing comes from each vendor's published pricing page; where a vendor publishes no rate, that is recorded rather than estimated.

Keep reading

The full rankings behind this comparison